| |
 |
|
Class Information
Number: 424/178.1
Name: Drug, bio-affecting and body treating compositions > Conjugate or complex of monoclonal or polyclonal antibody, immunoglobulin, or fragment thereof with nonimmunoglobulin material
Description: Subject matter involving a monoclonal or polyclonal antibody, immunoglobulin, or fragment thereof that is coupled to a nonimmunoglobulin material via a single covalent bond or via a linking chemical group, or which is coupled to a nonimmunoglobulin material via noncovalent means (e.g., via chelation or adsorption).
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/182.1 |
Conjugate includes potentiator; or composition comprising conjugate includes potentiator |
85 |
| 424/183.1 |
Conjugated to proteinaceous toxin or fragment thereof (e.g., conjugated to diphtheria toxin, pseudomonas exotoxin, ricin, gelonin, abrin, etc.) |
338 |
| 424/179.1 |
Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) |
283 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Nov. 17, 2009 |
| 7615221 |
Compositions and methods for treating cancer |
Nov. 10, 2009 |
| 7615223 |
Selected immunoconjugates for binding to aminophospholipids |
Nov. 10, 2009 |
| 7615224 |
Multiplex-bead complex for determination of lysosomal storage disorders |
Nov. 10, 2009 |
| 7611704 |
Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7612181 |
Dual variable domain immunoglobulin and uses thereof |
Nov. 3, 2009 |
| 7608405 |
Method of selectively assaying adiponectin multimers |
Oct. 27, 2009 |
| 7608579 |
Lung volume reduction using glue compositions |
Oct. 27, 2009 |
| 7608413 |
Kidney disease targets and uses thereof |
Oct. 27, 2009 |
| 7608259 |
Methods of cancer diagnosis and therapy targeted against a cancer stem line |
Oct. 27, 2009 |
| 7608268 |
Ferritin fusion proteins for use in vaccines and other applications |
Oct. 27, 2009 |
| 7608404 |
Disease determination method, data generation method for disease determination and data generation system for disease determination |
Oct. 27, 2009 |
| 7605235 |
Anti-tissue factor antibodies and compositions |
Oct. 20, 2009 |
| 7604953 |
Bioamplification for microbial sensor signal transduction |
Oct. 20, 2009 |
| 7601354 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
Oct. 13, 2009 |
| 7601814 |
Reducing the immunogenicity of fusion proteins |
Oct. 13, 2009 |
| 7597893 |
Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa |
Oct. 6, 2009 |
| 7597891 |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
Oct. 6, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7595044 |
Artery-and vein-specific proteins and uses therefor |
Sep. 29, 2009 |
| 7591994 |
Camptothecin-binding moiety conjugates |
Sep. 22, 2009 |
| 7589179 |
IL-7 variants with reduced immunogenicity |
Sep. 15, 2009 |
| 7589181 |
Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use |
Sep. 15, 2009 |
| 7585952 |
Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor |
Sep. 8, 2009 |
| 7582293 |
Anti-PRO6308 antibodies |
Sep. 1, 2009 |
| 7582288 |
Methods of targeting multiple cytokines |
Sep. 1, 2009 |
| 7575748 |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
Aug. 18, 2009 |
| 7572447 |
Methods and compositions for selective modulation of vascularization |
Aug. 11, 2009 |
| 7569673 |
Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
Aug. 4, 2009 |
| 7566451 |
Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency |
Jul. 28, 2009 |
| 7566453 |
Methods for treating melanomas |
Jul. 28, 2009 |
| 7563760 |
P-selectin ligand protein |
Jul. 21, 2009 |
| 7553810 |
Lung volume reduction using glue composition |
Jun. 30, 2009 |
| 7550141 |
Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids |
Jun. 23, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7550568 |
Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
Jun. 23, 2009 |
| 7550140 |
Antibody to the human OX40 receptor |
Jun. 23, 2009 |
| 7547436 |
Receptor specific transepithelial transport of therapeutics |
Jun. 16, 2009 |
| 7538086 |
PRO1303 polypeptides |
May. 26, 2009 |
| 7538195 |
Anti-IGF-I receptor antibody |
May. 26, 2009 |
| 7534869 |
Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
May. 19, 2009 |
| 7534417 |
103P2D6: tissue specific protein highly expressed in various cancers |
May. 19, 2009 |
| 7534430 |
Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
May. 19, 2009 |
| 7531174 |
Cripto blocking antibodies and uses thereof |
May. 12, 2009 |
| 7528239 |
Receptor that binds trail |
May. 5, 2009 |
| 7527787 |
Multivalent immunoglobulin-based bioactive assemblies |
May. 5, 2009 |
| 7524496 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
Apr. 28, 2009 |
| 7521054 |
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point |
Apr. 21, 2009 |
| 7521055 |
Ferroportin1 antibodies and methods |
Apr. 21, 2009 |
|
|
|
